GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing (CORRECTED)
Portfolio Pulse from Michael Juliano
GeneDx Holdings Corp. (NASDAQ:WGS) has led the Russell 2000 Index in 2024 with a 1,101% increase in share price, driven by a shift to more comprehensive genetic testing. Goldman Sachs has raised its price target for GeneDx from $12.50 to $28, maintaining a Neutral rating. Other top performers include Corbus Holdings Inc. (NASDAQ:CRBP) and Root, Inc. (NASDAQ:ROOT).
July 18, 2024 | 5:36 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Corbus Holdings Inc. (NASDAQ:CRBP) has risen 834% in 2024, making it one of the top performers in the Russell 2000 Index.
Corbus Holdings has shown significant share price growth, making it a notable performer in the small-cap space. However, the article does not provide specific details on the drivers behind this growth.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 50
POSITIVE IMPACT
Root, Inc. (NASDAQ:ROOT) has gained 670% in 2024, positioning it as one of the leading small-cap stocks in the Russell 2000 Index.
Root, Inc. has experienced substantial share price growth, making it a key performer in the small-cap segment. The article does not elaborate on the specific factors contributing to this rise.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 50
POSITIVE IMPACT
GeneDx Holdings Corp. (NASDAQ:WGS) has seen a 1,101% increase in share price in 2024 due to a shift to more comprehensive genetic testing. Goldman Sachs has raised its price target from $12.50 to $28, maintaining a Neutral rating.
The significant increase in share price and the raised price target from Goldman Sachs indicate strong positive momentum for GeneDx. The shift to more comprehensive genetic testing has improved margins and is expected to drive future growth.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100